|
1
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vehlow A and Cordes N: Invasion as target
for therapy of glioblastoma multiforme. Biochim Biophys Acta.
1836:236–244. 2013.PubMed/NCBI
|
|
3
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sanai N, Alvarez-Buylla A and Berger MS:
Neural stem cells and the origin of gliomas. N Engl J Med.
353:811–822. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Bao S, Wu Q, Wang H, Eyler C,
Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, et al:
Hypoxia-inducible factors regulate tumorigenic capacity of glioma
stem cells. Cancer Cell. 15:501–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee J, Kotliarova S, Kotliarov Y, Li A, Su
Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al:
Tumor stem cells derived from glioblastomas cultured in bFGF and
EGF more closely mirror the phenotype and genotype of primary
tumors than do serum-cultured cell lines. Cancer Cell. 9:391–403.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
10
|
Brescia P, Ortensi B, Fornasari L, Levi D,
Broggi G and Pelicci G: CD133 is essential for glioblastoma stem
cell maintenance. Stem Cells. 31:857–869. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Colin C, Baeza N, Tong S, Bouvier C,
Quilichini B, Durbec P and Figarella-Branger D: In vitro
identification and functional characterization of glial precursor
cells in human gliomas. Neuropathol Appl Neurobiol. 32:189–202.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nunes MC, Roy NS, Keyoung HM, Goodman RR,
McKhann G II, Jiang L, Kang J, Nedergaard M and Goldman SA:
Identification and isolation of multipotential neural progenitor
cells from the subcortical white matter of the adult human brain.
Nat Med. 9:439–447. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Miconi G, Palumbo P, Dehcordi SR, La Torre
C, Lombardi F, Evtoski Z, Cimini AM, Galzio R, Cifone MG and Cinque
B: Immunophenotypic characterization of human glioblastoma stem
cells: Correlation with clinical outcome. J Cell Biochem.
116:864–876. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stieber D, Golebiewska A, Evers L,
Lenkiewicz E, Brons NH, Nicot N, Oudin A, Bougnaud S, Hertel F,
Bjerkvig R, et al: Glioblastomas are composed of genetically
divergent clones with distinct tumourigenic potential and variable
stem cell-associated phenotypes. Acta Neuropathol. 127:203–219.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Son MJ, Woolard K, Nam DH, Lee J and Fine
HA: SSEA-1 is an enrichment marker for tumor-initiating cells in
human glioblastoma. Cell Stem Cell. 4:440–452. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lathia JD, Gallagher J, Heddleston JM,
Wang J, Eyler CE, Macswords J, Wu Q, Vasanji A, McLendon RE,
Hjelmeland AB, et al: Integrin alpha 6 regulates glioblastoma stem
cells. Cell Stem Cell. 6:421–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Visvader JE and Lindeman GJ: Cancer stem
cells: Current status and evolving complexities. Cell Stem Cell.
10:717–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ogden AT, Waziri AE, Lochhead RA, Fusco D,
Lopez K, Ellis JA, Kang J, Assanah M, McKhann GM, Sisti MB, et al:
Identification of A2B5+CD133- tumor-initiating cells in adult human
gliomas. Neurosurgery. 62:505–515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tchoghandjian A, Baeza N, Colin C, Cayre
M, Metellus P, Beclin C, Ouafik L and Figarella-Branger D: A2B5
cells from human glioblastoma have cancer stem cell properties.
Brain Pathol. 20:211–221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Friedl P and Alexander S: Cancer invasion
and the microenvironment: Plasticity and reciprocity. Cell.
147:992–1009. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Farahani E, Patra HK, Jangamreddy JR,
Rashedi I, Kawalec M, Rao Pariti RK, Batakis P and Wiechec E: Cell
adhesion molecules and their relation to (cancer) cell stemness.
Carcinogenesis. 35:747–759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bourboulia D and Stetler-Stevenson WG:
Matrix metalloproteinases (MMPs) and tissue inhibitors of
metalloproteinases (TIMPs): Positive and negative regulators in
tumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamamoto N, Tsuchiya H and Hoffman RM:
Tumor imaging with multicolor fluorescent protein expression. Int J
Clin Oncol. 16:84–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Zheng X, Jiang F, Zhang ZG,
Katakowski M and Chopp M: Dual-color fluorescence imaging in a nude
mouse orthotopic glioma model. J Neurosci Methods. 181:178–185.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Beier D, Hau P, Proescholdt M, Lohmeier A,
Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U and Beier
CP: CD133(+) and CD133(−) glioblastoma-derived cancer stem cells
show differential growth characteristics and molecular profiles.
Cancer Res. 67:4010–4015. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Joo KM, Kim SY, Jin X, Song SY, Kong DS,
Lee JI, Jeon JW, Kim MH, Kang BG, Jung Y, et al: Clinical and
biological implications of CD133-positive and CD133-negative cells
in glioblastomas. Lab Invest. 88:808–815. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Sakariassen PØ, Tsinkalovsky O,
Immervoll H, Bøe SO, Svendsen A, Prestegarden L, Røsland G, Thorsen
F, Stuhr L, et al: CD133 negative glioma cells form tumors in nude
rats and give rise to CD133 positive cells. Int J Cancer.
122:761–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
